Adial Pharmaceuticals, Inc

ADILNASDAQ • USD
1.63 USD
↗ 0.02 (1.14%)🟢PRE MARKET (AS OF 08:25 AM EDT)
🟢Market: OPEN
Open?$1.60
High?$1.61
Low?$1.57
Prev. Close?$1.58
Volume?1.0K
Avg. Volume?141.7K
VWAP?$1.58
Rel. Volume?0.01x
Bid / Ask
Bid?$1.57 × 100
Ask?$1.62 × 300
Spread?$0.05
Midpoint?$1.60
Valuation & Ratios
Market Cap?2.3M
Shares Out?1.4M
Float?1.4M
Float %?98.6%
P/E Ratio?N/A
P/B Ratio?0.43
EPS?-$5.59
Dividend?0.00%
Ex-Dividend?N/A
Technical Outlook
Loading...
Fundamental Outlook
Loading...
Short Interest
Loading...
Financial Health
Current Ratio?4.42Strong
Quick Ratio?4.42Strong
Cash Ratio?4.21Strong
Debt/Equity?0.00Low
ValuationATTRACTIVELY VALUED
Score
100/100
P/E?
N/A▾
P/B?
0.43CHEAP▾
P/S?
N/A▾
P/FCF?
N/A▾
EV/EBITDA?
0.5CHEAP▾
EV/Sales?
N/A▾
Returns & Efficiency
ROE?
-151.2%WEAK▾
ROA?
-119.5%WEAK▾
Cash Flow & Enterprise
FCF?N/A
Enterprise Value?$-3625024
Related Companies
Loading...
News
Profile
Adial Pharmaceuticals Inc is a clinical-stage biopharmaceutical company focused on the development of therapeutics for the treatment or prevention of addiction and related disorders. Its investigational new drug candidate, AD04, is being developed as a therapeutic agent for the treatment of alcohol use disorder. The company operates as one operating segment with a focus on drug development for addiction and related disorders.
Employees
6
Market Cap
2.2M
Industry
PHARMACEUTICAL PREPARATIONS
Website
www.adial.com
Listed
2018-07-27
Address
1180 SEMINOLE TRAIL
CHARLOTTESVILLE, VA 22901
Phone: 434-422-9800
MarketsMoversWatchlist